LEADER 01574nam2 2200349 450 001 000035594 005 20180710113119.0 100 $a20131203d1930----km-y0itaa50------ba 101 0 $aita 102 $aIT 200 1 $aAbruzzi e Molise$fL. Franciosa 210 $aRoma$cLibreria Internazionale F.lli Treves Dell'Ali$d1930 215 $a148 p., [1] carta di tav. ripieg.$d27 cm 225 2 $aStudi e monografie$fIstituto nazionale di economia agraria$v7 316 $aIn testa al frontespizio dell'esemplare FVig/41011: Gioacchino Viggiani 22 maggio 1930 410 0$12001$aStudi e monografie$v7 461 1$1001000035587$12001$aRapporti fra proprietą, impresa e mano d'opera nell'agricoltura italiana$v4 606 1 $aAziende agrarie$xRapporti di lavoro$yAbruzzo 606 1 $aAziende agrarie$xRapporti di lavoro$yMolise 676 $a338.7630945$v(22. ed.)$9Imprese. Agricoltura. Italia 676 $a330.94571$v(22. ed.)$9Situazioni e condizioni economiche. Abruzzo 700 1$aFranciosa,$bLuchino$f<1887-1983>$0339030 801 0$aIT$bUniversitą della Basilicata - B.I.A.$gREICAT$2unimarc 912 $a000035594 996 $aAbruzzi e Molise$91529755 997 $aUNIBAS CAT $aSTD093$b01$c20131203$lBAS01$h0907 CAT $aTTM$b30$c20140109$lBAS01$h0935 CAT $aATR$b20$c20180613$lBAS01$h1119 CAT $aATR$b20$c20180710$lBAS01$h1131 FMT Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2FVIG$BFondo Viggiani$3FVig/41011$641011$5T41011$7Collocato presso la Scuola di Agraria$820131203$f35$FStanza riservata LEADER 01027nam 2200373 450 001 9910480473703321 010 $a0-7022-5667-6 035 $a(CKB)3710000001418942 035 $a(MiAaPQ)EBC4882275 035 $a(EXLCZ)993710000001418942 100 $a20170717h19921992 uy 1 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 12$aA cage of butterflies /$fBrian Caswell 210 1$aQueensland, Australia :$cUniversity of Queensland Press,$d1992. 210 4$d©1992 215 $a1 online resource (122 pages) 606 $aEnglish fiction$y20th century 606 $aScience fiction 608 $aElectronic books. 615 0$aEnglish fiction 615 0$aScience fiction. 676 $a823.91408 700 $aCaswell$b Brian$f1954-$0932204 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910480473703321 996 $aA cage of butterflies$92097230 997 $aUNINA LEADER 05461nam 2200601 450 001 9910811249003321 005 20230803203641.0 010 $a92-4-069225-8 035 $a(CKB)3710000000198671 035 $a(EBL)1741837 035 $a(SSID)ssj0001381921 035 $a(PQKBManifestationID)12587706 035 $a(PQKBTitleCode)TC0001381921 035 $a(PQKBWorkID)11438286 035 $a(PQKB)11022400 035 $a(MiAaPQ)EBC1741837 035 $a(Au-PeEL)EBL1741837 035 $a(CaPaEBR)ebr10931308 035 $a(OCoLC)884015862 035 $a(EXLCZ)993710000000198671 100 $a20140925h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe selection and use of essential medicines $ereport of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children) /$fWorld Health Organization 210 1$aGeneva, Switzerland :$cWorld Health Organization,$d2014. 210 4$d©2014 215 $a1 online resource (235 p.) 225 1 $aWHO Technical Report Series ;$v985 300 $aDescription based upon print version of record. 311 $a92-4-120985-2 320 $aIncludes bibliographical references. 327 $aCover; Contents; Executive summary; List of participants; Declarations of interests; 1. Introduction; 2. Open session; 3. General items; 3.1 Defining public health relevance; 3.2 Medicines information as a global public good; 3.3 Other; 4. Applications only for paediatric medicines; Section 1: Anaesthetics; Anaesthetics (review) - Children; Section 2: Non-steroidal anti-inflammatory medicines (NSAIMs) and medicines used to treat gout and disease-modifying agents in rheumatoid disorders (DMARDs); 2.2: Opioid analgesics; Section 6: Anti-infective medicines; 6.2: Antibacterials 327 $a6.4: Antiviral medicines6.5: Antiprotozoal medicines; Section 8: Antineoplastics; 8.4: Medicines used in palliative care; Section 11: Blood products and plasma substitutes; 11.1: Plasma substitutes; Section 12: Cardiovascular medicines; 12.2: Antiarrhythmic medicines; 12.6: Lipid-lowering agents; Section 15: Disinfectants and antiseptics; 15.1: Antiseptics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 28: Ear, nose and throat medicines; Section 29: Specific medicines for neonatal care 327 $a5. Applications for the 18th Model List and the 4th EMLcSection 2: NSAIMs and DMARDs; 2.1: Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs); 2.3: Medicines used to treat gout; Section 3: Antiallergics and medicines used in anaphylaxis; Section 4: Antidotes and other substances used in poisonings; Section 6: Anti-infective medicines; 6.2: Antibacterials; 6.3: Antifungal medicines; 6.4: Antiviral medicines; 6.5: Antiprotozoal medicines; Section 8: Antineoplastics, immunosuppressives and medicines used in palliative care; 8.2: Cytotoxic and adjuvant medicines 327 $a8.4: Medicines used in palliative careSection 9: Antiparkinsonism medicines; Section 10: Medicines affecting the blood; 10.1: Antianaemia medicines; Section 11: Blood products and plasma substitutes; 11.2: Plasma fractions for specific use; Section 12: Cardiovascular medicines; 12.4: Medicines used in heart failure; Section 13: Dermatological medicines (topical); 13.4: Medicines affecting skin differentiation and proliferation; Section 17: Gastrointestinal medicines; 17.1: Antiulcer medicines; Section 18: Hormones, other endocrine medicines and contraceptives 327 $a18.5: Insulins and other medicines used for diabetesSection 21: Ophthalmological preparations; Section 22: Oxytocics and antioxytocics; 22.1: Oxytocics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 27: Vitamins and minerals; Section 28: Ear, nose and throat medicines; 6. Summary of recommendations; 18th WHO Model List of Essential Medicines; 4th Essential Medicines List for Children; Recommendations for reviews; References; Annex 1 18th WHO Model List of Essential Medicines (April 2013) 327 $aAnnex 2 4th WHO Model List of Essential Medicines for Children (April 2013) 330 $aThis report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model Lists of Essential Medicines. It contains a summary of the Committee's considerations and justifications for additions and changes to the Model Lists including its recommendations. Annexes to the main report include the revised version of the WHO Model List of Essential Medicines (18th edition) and the WHO Model List of Essential Medicines for Children (4th edition). In addition there is a list of all the items on the Model Lists sorted according to their Anatomical Therapeutic Chemical 410 0$aTechnical report series (World Health Organization) ;$v985. 606 $aDrug utilization$vCongresses 615 0$aDrug utilization 676 $a615.58 712 02$aWorld Health Organization. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910811249003321 996 $aThe selection and use of essential medicines$94031737 997 $aUNINA